Impact of the Treatment Line on the Risks and Benefits of Immune Checkpoint Inhibitors in Patients With Non-Small Cell Lung Cancer and Interstitial Lung Disease
Impact of the Treatment Line on the Risks and Benefits of Immune Checkpoint Inhibitors in Patients With Non-Small Cell Lung Cancer and Interstitial Lung Disease
复制标题
治疗系列对非小细胞肺癌和间质性肺病患者免疫检查点抑制剂风险和益处的影响
DOI：
10.1016/j.chest.2022.02.053
复制
发表时间：
2022
期刊：
影响因子：
9.6
通讯作者：
Kumanogoh Atsushi
中科院分区：
文献类型：
--
作者：
Matsumoto Kinnosuke;Shiroyama Takayuki;Yamamoto Yuji;Miyake Kotaro;Takeda Yoshito;Kumanogoh Atsushi
